ARCHIVES

FDA Throws Up IND Roadblock, Then Refuses To Answer Investigator’s Letters About It

This article is from The Cancer Letter archive.

Vol. 02 No. 06 | February 6, 1976

Download PDF Visit The Full Archive

Related Articles

NCI Seeks Changes In CIS Funding Plan With Next Recompetition

April 24, 1987

NCI Initiative: Start With Mechanism, Then answer The Many Questions, Klauser Says to Advisors

November 29, 1996

In Brief: Ira Kline, NCI researcher, Dead At 69; Massey Recruits Scientists; ACR Awards

October 15, 1993

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

FDA Tightens Conflict of Interest Rules For Advisors.

March 23, 2007

NCAB Subcommittee drafting Report Bioassay-Human Risk Relationship

February 16, 1979